DB15176InvestigationalProtein Based Therapies
Quilizumab is under investigation in clinical trial NCT01160861 (A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis).
- Mechanism
- Curator reviewed
Pharmacologically active on Immunoglobulin heavy constant epsilon
- Also known as
- MEMP1972A
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
Which drugs share a target with Quilizumab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account